Literature DB >> 3148514

Cyclophosphamide, epirubicin, vincristine and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.

P Comella, G Abate, M Fiore, G Di Finizio, W Polverino, P Muto, D Zarrilli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3148514

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

1.  Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, and bleomycin.

Authors:  P Comella; G Abate; G Di Finizio; A Daponte; D Zarrilli
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.